Yann Christinat
Université de Genève
H-index: 11
Europe-Switzerland
Top articles of Yann Christinat
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency–Associated Genomic Instability in Ovarian Cancer
JCO Precision Oncology
2024/3
PO009/# 424 Innovative academic homologous recombination deficiency tests available in advanced ovarian cancer: the European ENGOT initiative
2023/11/1
Yann Christinat
H-Index: 8
Toon Van Gorp
H-Index: 29
Normalized LST is an efficient biomarker for homologous recombination deficiency and Olaparib response in ovarian carcinoma
JCO Precision Oncology
2023/6
2022-RA-567-ESGO The Geneva HRD test: clinical validation on 469 samples from the PAOLA-1 trial
2022/10/1
572P High concordance of different molecular assays in the determination of HRD associated GIS in high grade epithelial ovarian cancer
Annals of Oncology
2022/9/1
SF3B1 facilitates HIF1-signaling and promotes malignancy in pancreatic cancer
Cell Reports
2022/8/23
Yann Christinat
H-Index: 8
Giovanni Pellegrini
H-Index: 12
Markus Stoffel
H-Index: 49
Gerald Schwank
H-Index: 18
Automated detection of arm-level alterations for individual cancer patients in the clinical setting
The Journal of Molecular Diagnostics
2021/12/1
727 HRD scoring with a SNP assay
International Journal of Gynecological Cancer
2021/10/1
201 Homologous recombination deficiency testing in advanced ovarian cancer: description of the ENGOT HRD European initiative
2021/10/1
Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab
Gynecologic Oncology Reports
2021/8/1
Yann Christinat
H-Index: 8
Petros Tsantoulis
H-Index: 12
SF3B1 promotes tumor malignancy through splicing-independent activation of HIF1α
bioRxiv
2020/11/10
Yann Christinat
H-Index: 8
Giovanni Pellegrini
H-Index: 12
Markus Stoffel
H-Index: 49
Gerald Schwank
H-Index: 18
Reliability of liquid biopsy analysis: an inter-laboratory comparison of circulating tumor DNA extraction and sequencing with different platforms
Laboratory Investigation
2020/11/1
Durable response to palbociclib and letrozole in ovarian cancer with CDKN2A loss
Cancer biology & therapy
2020/3/3
Yann Christinat
H-Index: 8
Petros Tsantoulis
H-Index: 12
Tissue-plasma TMB comparison and plasma TMB monitoring in patients with metastatic non-small cell lung cancer receiving immune checkpoint inhibitors
Frontiers in oncology
2020/2/12
Co-Authors
